Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

GtreeBNT receives approval for Phase IIb/III DES trial in South Korea

RegeneRx Biopharmaceuticals, Inc. has announced that its licensee, GtreeBNT Co. Ltd., has received approval from the Ministry of Food and Drug Safety, or MFDS, in South Korea to conduct a Phase IIb/III clinical trial in patients with dry eye syndrome, or DES.

Published By MarketLine
24 Jul 2015
NewsWire
NewsWire

NeoGenomics launches germline cancer predisposition testing services

NeoGenomics, Inc., a provider of cancer-focused genetic testing services, has launched a new line of germline cancer predisposition testing services.

Published By MarketLine
24 Jul 2015
NewsWire
NewsWire

Bristol-Myers receives EC approval for non-small cell lung cancer drug

Bristol-Myers Squibb Company has received the European Commission, or EC, approval for Nivolumab BMS indicated for the treatment of locally advanced or metastatic squamous, or SQ, non-small cell lung cancer, or NSCLC, after prior chemotherapy.

Published By MarketLine
24 Jul 2015
NewsWire
NewsWire

SHPL receives patent for Chi-Med's cardiovascular therapy in China

Hutchison China MediTech Limited, or Chi-Med, has announced that Shanghai Hutchison Pharmaceuticals Limited, or SHPL, has received an invention patent in China covering the formulation of Chi-Med's prescription drug for the treatment of cardiovascular diseases, She Xiang Bao Xin pill, or SXBXP, valid until 2029.

Published By MarketLine
24 Jul 2015
NewsWire
NewsWire

Nuffield Health and MSP plan to open diagnostic suite at Citylabs in UK

Nuffield Health, in partnership with Manchester Science Partnerships, or MSP, has announced its plan to open a diagnostic suite at Citylabs on Oxford Road in November.

Published By MarketLine
24 Jul 2015
NewsWire
NewsWire

Korian appoints new board member

Korian SA, a provider of temporary and permanent dependency care services, has appointed Timothy Leyne as a new member of the board of directors.

Published By MarketLine
24 Jul 2015
NewsWire
NewsWire

AUVA selects electronic health record from Cerner

The Allgemeine Unfallversicherungsanstalt, or AUVA, has selected Cerner Millennium electronic health record for its seven emergency hospitals and four rehabilitation centers.

Published By MarketLine
24 Jul 2015
NewsWire
NewsWire

Agenus signs licensing agreement with Diatheva for CEACAM1 antibodies

Agenus Inc., a biotechnology company, has signed a licensing agreement with Diatheva s.r.l. for antibodies targeting Carcinoembryonic antigen cell adhesion molecule 1, or CEACAM1, a glycoprotein expressed on T cell and NK cell lymphocytes.

Published By MarketLine
24 Jul 2015
NewsWire
NewsWire

Boston Scientific initiates atherosclerotic coronary lesion study

Boston Scientific Corporation, a medical device company, has initiated a study with its fully resorbable drug-eluting scaffold system for treatment of atherosclerotic coronary lesions.

Published By MarketLine
24 Jul 2015
NewsWire
NewsWire

AstraZeneca and Kyowa Hakko to commercialize asthma and COPD drug in Japan

AstraZeneca plc has signed an agreement with Kyowa Hakko Kirin Co. Ltd., a biotechnology company, to commercialize benralizumab for the treatment of asthma and chronic obstructive pulmonary disease, or COPD, in Japan.

Published By MarketLine
24 Jul 2015

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.